H. Seidel

Directeur/Membre du Conseil chez THIRD HARMONIC BIO, INC.

Profil

H.
Martin Seidel currently works at IFM Therapeutics LLC, as Chief Executive Officer & Director from 2019, IFM Cinque, Inc., as Chief Executive Officer, IFM Continua, Inc., as Chief Executive Officer, IFM Quattro, Inc., as Chief Executive Officer, Third Harmonic Bio, Inc., as Independent Director from 2019, and Atlas Venture Advisors, Inc., as Advisor.
Dr. Seidel also formerly worked at DuPont Pharmaceuticals Co., as Director from 2001 to 2003, Novartis Institute for Functional Genomics, Inc., as Institute Director, Novartis Institute for Functional Genomics, Inc., as Director-Institute & Site Head from 2010 to 2014, and Novartis Institutes for Biomedical Research, Inc., as Global Head-Strategic Alliances from 2014 to 2017.
Dr. Seidel received his doctorate degree in 1992 from Harvard University and undergraduate degree in 1986 from Princeton University.

Postes actifs de H. Seidel

Sociétés	Poste	Début
THIRD HARMONIC BIO, INC.	Directeur/Membre du Conseil	01/07/2019
IFM Therapeutics LLC	Directeur Général	02/12/2019
IFM Quattro, Inc.	Directeur Général	-
IFM Cinque, Inc.	Directeur Général	-
IFM Continua, Inc.	Directeur Général	-
Atlas Venture Advisors, Inc.	Consultant / Advisor	-

Anciens postes connus de H. Seidel

Sociétés	Poste	Fin
Novartis Institutes for Biomedical Research, Inc.	Corporate Officer/Principal	01/06/2017
Novartis Institute for Functional Genomics, Inc.	Corporate Officer/Principal	01/01/2014
DuPont Pharmaceuticals Co.	Directeur/Membre du Conseil	31/12/2003
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-